Ilsung Pharma under fire over delayed law action

Published: 2012-03-09 06:59:00

Updated: 2012-03-09 06:59:00

Ilsung Pharmaceutical Co. is under fire after it failed to take a lead in legal action against the government over the latter’s plan to slash drug prices in April.

Industry sources said small-sized Dalim Biotech and KMS Pharma on Wednesday lodged their suits against the Health Ministry as a fi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK